Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.

NCT00412048 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT00412048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00412048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.
Lead sponsor
University Hospital, Strasbourg, France
Phase
Not applicable
Overall status
Withdrawn
Start date
April 30, 2012
Completion date
February 28, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease